Intro offer
100 days of Premium for just $10.
Try all Premium features for over 3 months and analyze stocks without limits.
Try 100 days for $10

₩1,396,000.00
0.92%
Korea, Sep 17, 03:30 pm KST. Closed.
ISIN
KR7207940008
Symbol
207940
Index

SAMSUNG BIOLOGICS Stock price

₩1,396,000.00
-152,000.00 9.82% 1M
+396,000.00 39.60% 6M
+396,000.00 39.60% YTD
+972,991.55 230.02% 1Y
+972,991.55 230.02% 3Y
+972,991.55 230.02% 5Y
+1,253,512.58 879.74% 10Y
+1,253,512.58 879.74% 20Y
Korea, Closing price Thu, Sep 17 2026
-13,000.00 0.92%
ISIN
KR7207940008
Symbol
207940
Index

Is SAMSUNG BIOLOGICS a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
₩65.4t
Enterprise Value
₩64.4t
Net debt
positive
Cash
₩2.2t
Shares outstanding
46.2m
Valuation (TTM | estimate)
P/E
32.8
P/S
14.4 | 11.9
EV/Sales
14.2 | 11.7
EV/FCF
40.9
P/B
7.8
Financial Health
Equity Ratio
67.4%
Return on Equity
24.0%
ROCE
23.5%
ROIC
20.5%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
₩4.5t | ₩5.5t
EBITDA
₩2.3t
EBIT
₩2.3t
Net Income
₩2.0t
Free Cash Flow
₩1.6t
Growth (TTM | estimate)
Revenue
-9.6% | 20.7%
EBITDA
37.5%
EBIT
39.8%
Net Income
54.3%
Free Cash Flow
307.1%
Margin
Gross
53.8%
EBITDA
50.7%
EBIT
50.0%
Net
43.6%
Free Cash Flow
34.6%
More
EPS
₩42,913.8
FCF per Share
₩34,054.4
Short interest
-
Employees
5k
Rev per Employee
₩877.2m

SAMSUNG BIOLOGICS Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a SAMSUNG BIOLOGICS forecast:

32x Buy
97%
1x Hold
3%

Analyst Opinions

33 Analysts have issued a SAMSUNG BIOLOGICS forecast:

Buy
97%
Hold
3%

Financial data from SAMSUNG BIOLOGICS

Jun '26
+/-
%
4,546,823 4,546,823
10% 10%
100%
- Direct Costs 2,102,233 2,102,233
11% 11%
46%
2,444,590 2,444,590
8% 8%
54%
- Selling and Administrative Expenses 143,161 143,161
83% 83%
3%
- Research and Development Expense 50,551 50,551
70% 70%
1%
2,306,084 2,306,084
38% 38%
51%
- Depreciation and Amortization 31,954 31,954
36% 36%
1%
EBIT (Operating Income) EBIT 2,274,129 2,274,129
40% 40%
50%
Net Profit 1,984,312 1,984,312
54% 54%
44%

In millions KRW.

Don't miss a Thing! We will send you all news about SAMSUNG BIOLOGICS directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

SAMSUNG BIOLOGICS Co., Ltd. engages in the provision of contract manufacturing organization services for pharmaceutical products. The company was founded on April 22, 2011 and is headquartered in Incheon, South Korea.

Head office South Korea
CEO Mr. Rim
Employees 5,195
Founded 2011
Website samsungbiologics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today